Süt dişi pulpotomi tedavilerinde kullanılan hemostatik ajanlar

Süt dişlerindeki mine ve dentin kalınlığının daimi dişlere göre daha az olması, pulpa odasının daimi dişlere göre göreceli olarak daha geniş olması ve süt dişlerinde pulpa boynuzlarının yüzeye daha yakın olması sebebi ile pulpal tedavi gereksinimi daimi dişlere göre daha fazla görülmektedir. Çocuk diş hekimliğinde pulpotomi tedavisi sıklıkla kullanılan bir yöntemdir ve tedavinin başarısında kullanılan materyal önemli faktörlerden biridir. Pıhtı formasyonu iyileşmeyi olumsuz etkilediği gibi bakteriler için uygun bir ortam oluşturup bölgede enflamasyon ve enfeksiyonu tetikleyebilmekte, ayrıca pulpa dokusu ile üzerine konulan medikamentin temasını engellediği için tedavi başarısını düşürmektedir. Bu yüzden pulpotomi tedavisinde kalan pulpa dokusunda pıhtıyı ortadan kaldıran etkili bir hemostazın tedavinin başarısını artırıcı bir rol oynadığı düşünülmektedir. Bu nedenlerden dolayı hemostatik ajanlar pulpotomi tedavilerinde kullanılmaya başlanmıştır. Bu makalede, çocuk diş hekimliği pratiğinde pulpotomi tedavilerinde kullanılan farklı hemostatik ajanların derlenmesi amaçlanmıştır.

Hemostatic agents for pulpotomy treatment in primary teeth

The need for pulpal treatment in the primary teeth is greater than the permanent teeth, because in primary teeth enamel and dentin is thinner, the pulp chamber is relatively wider and pulp horns are closer to the surface than permanent teeth. Pulpotomy is a frequently used method in pediatric dentistry and for the success of the treatment material is an important factor. Clot formation affects healing as well as it can create a favorable environment for the bacteria to induce inflammation and infection and also decreases the success of the treatment by preventing the pulp tissue- medicament contact. Therefore, it is believed that an effective haemostasis, increases treatment success. For these reasons hemostatic agents have begun to be used in pulpotomy treatments. The purpose of this paper is to review various hemostatic agents used in pulpotomy treatment in pediatric dentistry practice.

PDF

___

Fejerskov ONB, Kidd, E.A.M. Clinical and Histologic Manifestations of Dental Caries. Copenhagen: Blackwell Munksgaard; 2003.
Caufield PW, Cutter GR, Dasanayake AP. Initial acquisition of mutans streptococci by infants: evidence for a discrete window of infectivity. J Dent Res 1993; 72: 37-45.
Fuks ABKA, Guelmann, M. Pulp Therapy for the Primary Dentition Pediatric Dentistry Infancy Through Adolescence. Elsevier Saunders: St. Louis, Missouri; 2013.
Simancas-Pallares MA, Diaz-Caballero AJ, Luna-Ricardo LM. Mineral trioxide aggregate in primary teeth pulpotomy. A systematic literature review. Med Oral Patol Oral Cir Bucal 2010; 15: e942-946.
Nadin G, Goel BR, Yeung CA, Glenny AM. Pulp treatment for extensive decay in primary teeth. Cochrane Database Syst Rev 2003:CD003220.
Pinkham JR. Pediatric Dentistry: Infancy Through Adolescence. Philadelphia: W.B.Saunders Company; 1999.
Dean JA, Mack RB, Fulkerson BT, Sanders BJ. Comparison of electrosurgical and formocresol pulpotomy procedures in children. Int J Paediatr Dent 2002; 12: 177-182.
Liu JF, Chen LR, Chao SY. Laser pulpotomy of primary teeth. Pediatr Dent 1999; 21: 128-129.
Ansari G, Ranjpour M. Mineral trioxide aggregate and formocresol pulpotomy of primary teeth: a 2-year follow-up. Int Endod J 2010; 43: 413-418.
Fuks AB, Bimstein E, Guelmann M, Klein H. Assessment of a 2 percent buffered glutaraldehyde solution in pulpotomized primary teeth of schoolchildren. ASDC J Dent Child 1990; 57: 371-375.
Ibricevic H, Al-Jame Q. Ferric sulphate and formocresol in pulpotomy of primary molars: long term follow-up study. Eur J Paediatr Dent 2003; 4: 28-32.
Nakashima M. Induction of dentin formation on canine amputated pulp by recombinant human bone morphogenetic proteins (BMP)-2 and -4. J Dent Res 1994; 73: 1515-1522.
Asgary S, Ahmadyar M. Vital pulp therapy using calcium-enriched mixture: An evidence-based review. J Conserv Dent 2013; 16: 92-98.
Yaman E, Gorken F, Pinar Erdem A, Sepet E, Aytepe Z. Effects of folk medicinal plant extract Ankaferd Blood Stopper((R)) in vital primary molar pulpotomy. Eur Arch Paediatr Dent 2012; 13: 197-202.
Odabas ME, Cinar C, Tulunoglu O, Isik B. A new haemostatic agent's effect on the success of calcium hydroxide pulpotomy in primary molars. Pediatr Dent 2011; 33: 529-534.
Lewis BB, Chestner SB. Formaldehyde in dentistry: a review of mutagenic and carcinogenic potential. J Am Dent Assoc 1981; 103: 429-434.
Milnes AR. Is formocresol obsolete? A fresh look at the evidence concerning safety issues. J Endod 2008; 34: S40-46.
Camp JHF, A.B. Pediatrics: endodontic treatment for the primary and young permanent dentition. St. Louis: Mosby Elsevier; 2006.
International Agency for Research on Cancer WHO, Press Release No. 153 J, 2004. Available from: URL: http:// www.iarc.fr/ENG/Press_Releases/archives/pr153a.html (accessed October 7, 2005).
Fuks AB, Michaeli Y, Sofer-Saks B, Shoshan S. Enriched collagen solution as a pulp dressing in pulpotomized teeth in monkeys. Pediatr Dent 1984; 6: 243-247.
McDonald RE AD, Dean JA. Dentistry for the Child and Adolescent. St. Louis: Mo: Mosby Co; 2004.
Berger JE. A review of the erroneously labeled "mummification" techniques of pulp therapy. Oral Surg Oral Med Oral Pathol 1972; 34: 131-144.
Boller RJ. Reactions of pulpotomized teeth to zinc oxide and formocresol-type drugs. ASDC J Dent Child 1972; 39: 298-307.
Hansen HP, Ravn JJ, Ulrich D. Vital pulpotomy in primary molars. A clinical and histologic investigation of the effect of zinc oxide-eugenol cement and Ledermix. Scand J Dent Res 1971; 79: 13-25.
Ghoddusi J, Shahrami F, Alizadeh M, Kianoush K, Forghani M. Clinical and radiographic evaluation of vital pulp therapy in open apex teeth with MTA and ZOE. N Y State Dent J 2012; 78: 34-38.
Ranly DM, Garcia-Godoy F, Horn D. Time, concentration, and pH parameters for the use of glutaraldehyde as a pulpotomy agent: an in vitro study. Pediatr Dent 1987; 9: 199-203.
Tagger E, Tagger M. Pulpal and periapical reactions to glutaraldehyde and paraformaldehyde pulpotomy dressing in monkeys. J Endod 1984; 10: 364-371.
Shumayrikh NM, Adenubi JO. Clinical evaluation of glutaraldehyde with calcium hydroxide and glutaraldehyde with zinc oxide eugenol in pulpotomy of primary molars. Endod Dent Traumatol 1999; 15: 259-264.
Magnusson B. Therapeutic pulpotomy in primary molars--clinical and histological follow-up. I. Calcium hydroxide paste as wound dressing. Odontol Revy 1970; 21: 415-431.
Schroder U. A 2-year follow-up of primary molars, pulpotomized with a gentle technique and capped with calcium hydroxide. Scand J Dent Res 1978; 86: 273-278.
Ranly DM, Garcia-Godoy F. Current and potential pulp therapies for primary and young permanent teeth. J Dent 2000; 28: 153-161.
Markovic D, Zivojinovic V, Vucetic M. Evaluation of three pulpotomy medicaments in primary teeth. Eur J Paediatr Dent 2005; 6: 133-138.
Noorollahian H. Comparison of mineral trioxide aggregate and formocresol as pulp medicaments for pulpotomies in primary molars. Br Dent J 2008; 204: E20.
Fallahinejad Ghajari M, Mirkarimi M, Vatanpour M, Kharrazi Fard MJ. Comparison of pulpotomy with formocresol and MTA in primary molars: a systematic review and meta- analysis. Iran Endod J 2008; 3: 45-49.
Godhi B, Tyagi R. Success Rate of MTA Pulpotomy on Vital Pulp of Primary Molars: A 3-Year Observational Study. Int J Clin Pediatr Dent 2016; 9: 222-227.
Lin PY, Chen HS, Wang YH, Tu YK. Primary molar pulpotomy: a systematic review and network meta-analysis. J Dent 2014; 42: 1060-1077.
Shirvani A, Asgary S. Mineral trioxide aggregate versus formocresol pulpotomy: a systematic review and meta-analysis of randomized clinical trials. Clin Oral Investig 2014; 18: 1023-1030.
Anthonappa RP, King NM, Martens LC. Is there sufficient evidence to support the long-term efficacy of mineral trioxide aggregate (MTA) for endodontic therapy in primary teeth? Int Endod J 2013; 46: 198-204.
Coll JA, Seale NS, Vargas K, Marghalani AA, Al Shamali S, Graham L. Primary Tooth Vital Pulp Therapy: A Systematic Review and Meta-analysis. Pediatr Dent 2017; 39: 16-123.
Tuloglu N, Bayrak S. Partial Pulpotomy with BioAggregate in Complicated Crown Fractures: Three Case Reports. J Clin Pediatr Dent 2016; 40: 31-35.
Chang SW, Lee SY, Kum KY, Kim EC. Effects of ProRoot MTA, Bioaggregate, and Micromega MTA on odontoblastic differentiation in human dental pulp cells. J Endod 2014; 40: 113-118.
Collado-Gonzalez M, Garcia-Bernal D, Onate-Sanchez RE, Ortolani-Seltenerich PS, Alvarez-Muro T, Lozano A . Cytotoxicity and bioactivity of various pulpotomy materials on stem cells from human exfoliated primary teeth. Int Endod J 2017; 50 Suppl 2: e19-e30.
Grewal N, Salhan R, Kaur N, Patel HB. Comparative evaluation of calcium silicate-based dentin substitute (Biodentine(R)) and calcium hydroxide (pulpdent) in the formation of reactive dentin bridge in regenerative pulpotomy of vital primary teeth: Triple blind, randomized clinical trial. Contemp Clin Dent 2016; 7: 457-463.
Nowicka A, Lipski M, Parafiniuk M, Sporniak-Tutak K, Lichota D, Kosierkiewicz A . Response of human dental pulp capped with biodentine and mineral trioxide aggregate. J Endod 2013; 39: 743-747.
Marconyak LJ Jr KT, Roberts HW, Roberts MD, Aparicio A, Himel VT, Sabey KA. A Comparison of Coronal Tooth Discoloration Elicited by Various Endodontic Reparative Materials. J Endod 2016; 42: 470-473.
Hirschman WR, Wheater MA, Bringas JS, Hoen MM. Cytotoxicity comparison of three current direct pulp-capping agents with a new bioceramic root repair putty. J Endod 2012; 38: 385-388.
Rutherford RB, Wahle J, Tucker M, Rueger D, Charette M. Induction of reparative dentine formation in monkeys by recombinant human osteogenic protein-1. Arch Oral Biol 1993; 38: 571-576.
Nakashima M. The induction of reparative dentine in the amputated dental pulp of the dog by bone morphogenetic protein. Arch Oral Biol 1990; 35: 493-497.
Agamy HA, Bakry NS, Mounir MM, Avery DR. Comparison of mineral trioxide aggregate and formocresol as pulp-capping agents in pulpotomized primary teeth. Pediatr Dent 2004; 26: 302-309.
Mooney GC, North S. The current opinions and use of MTA for apical barrier formation of non-vital immature permanent incisors by consultants in paediatric dentistry in the UK. Dent Traumatol 2008; 24: 65-69.
Landau MJ, Johnsen, D.C. Pulpal responses to ferric sulfate in monkeys. J Dent Res 1988; 67: 215.
Vargas KG, Packham B, Lowman D. Preliminary evaluation of sodium hypochlorite for pulpotomies in primary molars. Pediatr Dent 2006; 28: 511-517.
Haghgoo R, Abbasi F. A histopathological compari son of pulpotomy with sodium hypochlorite and formoc -resol. Iran Endod J 2012; 7: 60-62.
Shabzendedar M, Mazhari F, Alami M, Talebi M. So -dium hypochlorite vs formocresol as pulpotomy medica -ments in primary molars: 1-year follow-up. Pediatr Dent 2013; 35: 329-332.
Farsi DJ, El-Khodary HM, Farsi NM, El Ashiry EA, Yag -moor MA, Alzain SM. Sodium Hypochlorite Versus For -mocresol and Ferric Sulfate Pulpotomies in Primary Mo -lars: 18-month Follow-up. Pediatr Dent 2013; 37: 535-540.
Cantekin K, Gumus H. Success Rates of Ankaferd Blo -od Stopper and Ferric Sulfate as Pulpotomy Agents in Pri-mary Molars. Int Sch Res Notices 2014: 8: 819605.
Nicolson JW. Biologic Considerations. Fundamentals of Operative Dentistry: A Contemporary Approach. Hano -ver Park: Ouintessence Publishing 1996.
Mjor IA. The exposed pulp Pulp-dentin biology in res -torative dentistry: Quintessence Int 2002; 33: 113-135.
Torabinejad MW, R.E. Endodontics Principles and Pra -ctice. W.B. Saunders Co; 2009.
Shen EC, Chou TC, Gau CH, Tu HP, Chen YT, Fu E. Releasing growth factors from activated human platelets after chitosan stimulation: a possible bio-material for platelet-rich plasma preparation. Clin Oral Implants Res 2006; 17: 572-578.
SHANG Jia-jian GL-h, LIU Xiao-yong,ZHAO Bao-rong, - NIU Jing-lu,YANG Sheng-hui. Experimental study of chito - san on vital pulpotomy in primary teeth. Beijing Journal of Stomatology 2011; 4.
Balata GF AM, Mahmoud GM, Matar MA, Abd El-La - tif AN. Formulation of Saudi propolis into biodegradable chitosan chips for vital pulpotomy. Curr Drug Deliv 2017; 4: 100-118.